Related Experiment Video
Updated: Aug 12, 2025
08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
442
Recent applications of computational methods to allosteric drug discovery
Rajiv Gandhi Govindaraj1, Sundar Thangapandian1, Michael Schauperl1
1Computational Chemistry, HotSpot Therapeutics Inc., Boston, MA, United States.
Frontiers in Molecular Biosciences
|January 30, 2023
Summary
Structure-based drug design is advancing allosteric drug discovery. Allosteric sites offer unique advantages for developing selective and tolerable therapeutics by leveraging protein flexibility and function.
Area of Science:
- Pharmacology and Medicinal Chemistry
- Structural Biology
- Drug Discovery
Background:
- Growing interest in allosteric sites for novel therapeutic development over the past 20 years.
- Allosteric sites offer greater selectivity and tolerability compared to orthosteric sites due to lower conservation across protein families.
Purpose of the Study:
- To examine the impact of structure-based drug design (SBDD) on allosteric drug discovery.
- To highlight key targets across various classes where SBDD is influencing allosteric therapeutic strategies.
Main Methods:
- Review and analysis of current structure-based drug design approaches applied to allosteric targets.
- Examination of protein flexibility and its role in allosteric site function and drug design.
Main Results:
- Structure-based drug design principles are being adapted to address the unique challenges of allosteric sites.
- Understanding protein flexibility is crucial for successful allosteric drug design.
- Several examples demonstrate the impact of SBDD on diverse allosteric targets.
Conclusions:
- Structure-based drug design is a significant and growing influence in the field of allosteric drug discovery.
- Further research into protein dynamics will enhance the development of selective allosteric therapeutics.
Related Concept Videos
01:26Drug Discovery: Overview
8.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K
01:28Structure-Activity Relationships and Drug Design
835
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
835
01:58Cooperative Allosteric Transitions
2.3K
2.3K
01:26Targets for Drug Action: Overview
6.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.9K
01:22Protein-Drug Binding: Determination Methods
255
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
255
01:16Protein-Drug Binding: Mechanism and Kinetics
714
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
714